openPR Logo
Press release

Venous Thromboembolism Treatment Market Analysis, Segments, Growth and Value Chain 2016-2026

01-25-2017 10:14 AM CET | Health & Medicine

Press release from: Future Market Insights

Venous Thromboembolism Treatment Market Analysis, Segments,

Venous Thromboembolism (VTE) is formation of blood clot in the vein. It includes both Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). When a clot forms in a deep vein, usually in the leg, it is called a deep vein thrombosis. If that clot breaks loose and travels to the lungs, it is called pulmonary embolism. Long term complications of venous thromboembolism include chronic thromboembolic pulmonary hypertension (CTPH) and the post-thrombotic syndrome (PTS).

Venous thromboembolism is third most common cardiovascular disease occurred in the world. Common symptoms of venous thromboembolism include edema, dilated blood veins mainly in chest and legs, dyspnea, tachycardia and fever. The lower extremities are the most common site for DVT, but other affected locations include the upper extremities and the mesenteric and the pelvic veins, as well as the cerebral veins.

Venous Thromboembolism Treatment Market:Drivers and Restraints

Major factors such as increasing morbidity rate of venous thromboembolism and increasing awareness about available treatments for venous thromboembolism are driving the global venous thromboembolism treatment market towards growth. On the other hand, factors such as stringent regulatory approvals and challenges in adaption of newer drug in the market are restraining the growth of this market.

Venous Thromboembolism Treatment Market:Segmentation

Venous thromboembolism treatment market is segmented on the basis of product type, end use and geography.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1341

Based on product type, the global market of venous thromboembolism treatment is segmented as follows:

Medications

Anticoagulants

Heparin

Factor Xa inhibitors

Fondaparinux

Dabigatran

Vitamin K antagonists

Warfarin

Compression Therapy

Surgical treatment

Pulmonary embolectomy

Vena caval interruption

Based on end use, venous thromboembolism treatment market can be segmented as follows:

Hospitals including hospital pharmacies

Clinics

Retail pharmacies

Home care settings

Venous Thromboembolism Treatment Market: Overview

With rise in the aging population, morbidity rate of venous thromboembolism is also rapidly increasing. The mainstay of venous thromboembolism treatment is anticoagulation. However, anticoagulants will probably always increase bleeding risk. Hence, using both heparin and compression stockings appears better than either one alone in reducing the rate of deep vein thrombosis. Medications to treat venous thromboembolism like heparin, dabigatran has shown promise. Vitamin K antagonists are also commonly used. Acute DVT may be treated in an outpatient setting with low-molecular-weight heparin. Hence, these medicinal therapies are responsible for the growth of venous thromboembolism treatment market.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1341

Venous Thromboembolism Treatment Market:Region-wise Outlook

Region wise, the venous thromboembolism treatment marketis classified into countries namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is the dominant regional market for venous thromboembolism treatments and is followed by Europe due the existence of a lathe number of venous thromboembolic patients in these regions. North America and European venous thromboembolism market is driven by high healthcare spending, improved healthcare infrastructure and high awareness about the disease and available treatments. Asia Pacific is a promising market for venous thromboembolism treatment and is expected to undergo rapid market growth due to increase in purchasing power, changing healthcare infrastructure and increased awareness for clinical facilities.

Venous Thromboembolism Treatment Market: Key Players

Some of the major companies contributing to venous thromboembolism treatment market are Sanofi-Aventis, Upsher-Smith Laboratories, Abbott Laboratories, Merck & Co., Wockhardt Ltd, Bayer Biologicals, Dupont Pharm Co, Bristol-Myers Squibb Company and Pfizer Inc.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Press: press@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Venous Thromboembolism Treatment Market Analysis, Segments, Growth and Value Chain 2016-2026 here

News-ID: 421265 • Views:

More Releases from Future Market Insights

Glass Bottles Market Set to Soar at 5.70% CAGR, Empowering Manufacturers with Sustainable Growth
Glass Bottles Market Set to Soar at 5.70% CAGR, Empowering Manufacturers with Su …
The global glass bottles market is entering a transformative phase, projected to expand from USD 44.9 billion in 2025 to USD 78.2 billion by 2035, representing a CAGR of 5.7%. This trajectory underscores a robust opportunity for manufacturers to align operations with rising demand for sustainable and premium packaging solutions across diverse industries. Sales in 2024 reached USD 42.4 billion, reflecting a consistent growth momentum that signals confidence in market
Passive Temperature-Controlled Packaging Market Set to Grow at 5.48% CAGR in India, Unlocking New Opportunities for Manufacturers
Passive Temperature-Controlled Packaging Market Set to Grow at 5.48% CAGR in Ind …
The Indian passive temperature-controlled packaging solutions market is poised for significant expansion, with projected growth at a CAGR of 5.48% over the next decade. Valued at USD 13,865 million globally in 2024, the industry is anticipated to nearly double to USD 28,137 million by 2034. This growth trajectory presents manufacturers with an unparalleled opportunity to cater to evolving market demands across pharmaceuticals, food and beverage, chemicals, and biotechnology sectors. Meeting Critical
Bag in Tube Market Set to Grow 6.7% in India, Unlocking New Opportunities for Manufacturers
Bag in Tube Market Set to Grow 6.7% in India, Unlocking New Opportunities for Ma …
The global bag in tube market is entering a phase of transformative growth, expected to rise from USD 5.6 million in 2024 to USD 8.7 million by 2034, representing a steady CAGR of 4.5%. The market's expansion reflects broader trends in sustainable packaging, convenience, and material innovation. For manufacturers, this presents a compelling opportunity to adopt forward-looking strategies that align with evolving consumer preferences and regulatory demands. Sustainability and Consumer Convenience
India's Packaging Barrier Film Market Poised for 6.5% Growth Through 2034
India's Packaging Barrier Film Market Poised for 6.5% Growth Through 2034
The Packaging Barrier Film market is entering a decade of sustained growth, with its valuation expected to reach USD 24.5 billion by 2034 from USD 18.8 billion in 2024, reflecting a steady CAGR of 2.7%. For manufacturers, this market offers unparalleled opportunities to capitalize on evolving consumer needs, regulatory shifts, and technological advancements in packaging solutions. With the rapid production of electronic goods worldwide, packaging barrier films are increasingly being recognized

All 5 Releases


More Releases for Venous

States Venous Stents Market Projected to Witness Expansion with Rising Incidence …
States Venous Stents Market Overview The States Venous Stents Market is expected to grow from USD 1.3 billion in 2025 to USD 2.4 billion by 2032, registering a CAGR of 8.9%. Coherent Market Insights is pleased to release its latest States Venous Stents Market research report, offering an in-depth analysis of the U.S. States Venous Stents Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels,
Venous Stent Market Grows with Rising Cases of Chronic Venous Disorders | Boston …
Venous Stent Market Overview The venous stent market is anticipated to grow from USD 0.6 billion in 2025 to USD 1.3 billion by 2032, exhibiting a CAGR of 10.3% during the forecast period. Coherent Market Insights is proud to announce the release of its latest market research report, providing a comprehensive analysis of the Venous Stent Market Landscape from 2025 to 2032. This report delivers precise forecasts across global, regional, and country
Major Force in the Venous Thromboembolism Market 2025: Impact Of Healthcare Infr …
How Will the Venous Thromboembolism Market Grow, and What Is the Projected Market Size? Over the past few years, the venous thromboembolism market has experienced a steady increase in its size. It's projected to expand from $2.44 billion in 2024 to $2.55 billion in 2025, rising at a compound annual growth rate (CAGR) of 4.4%. The growth during the historic period can be credited to an increasing elderly population, progress in
Venous Catheter Market Size 2024 to 2031.
Market Overview and Report Coverage A venous catheter is a small, flexible tube inserted into a vein for medical purposes such as accessing the bloodstream for medications, fluids, or blood sampling. The venous catheter market is expected to witness significant growth in the coming years, with a projected CAGR of 6.30% during the forecasted period. The current outlook for the venous catheter market is positive, driven by factors such as
Venous Skin Ulcer Treatment Market : Lucrative Opportunities
Venous Skin Ulcer Treatment Market: Introduction According to the report, the global venous skin ulcer treatment market was valued at US$ 2.6 Bn in 2019. It is expected to expand at a CAGR of ~5% during the forecast period from 2020 to 2030. Various advanced technologies and treatment options are presently available for venous skin ulcer. The treatment for skin ulcer include different therapies such as compression therapy, advanced wound dressings,
Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism. Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188 Pulmonary embolism occurs in almost one-third of patients